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ABSTRACT 
A putative ginsenosidase (PiGH1-x) from the oomycete pathogen of American Ginseng, 
Pythium irregulare, was expressed in E. coli DH5α to assess its capability to partially 
deglycosylate ginsenosides. The recombinant protein was extracted using non-denaturing 
and denaturing conditions and purified using gel filtration chromatography and nickel 
affinity purification. Glycosidase activity was tested using p-nitrophenyl β-D-
glucopyranoside (pNPG) as the substrate and measured through spectrophotometry. 
Ginsenosidase activity was tested using ginsenoside Rb1 as the substrate,  reaction 
products were identified using LC-MS. Recombinant PiGH1-x cleaved glucose from 
pNPG, and converted ginsenoside Rb1 into Rd and Gypenoside XVII, demonstrating 
both (12) and (16) glycosidase activity. While a high yield of recombinant protein 
was observed, protein aggregation interfered with the purification process, and further 
optimization is required. Since previous work has correlated ginsenoside deglycosylation 
with infection severity, these findings suggest that PiGH1-x may have an important role 
in the pathogenicity of P. irregulare towards American Ginseng. 
Keywords: Pythium irregulare, American Ginseng, ginsenosides, ginsenosidase, 
glycosidase. 
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1 INTRODUCTION 
1.1 Ginseng overview 
Ginseng is a widely studied medicinal plant that belongs to the genus Panax in the 
Araliaceae (Wen and Zimmer, 1996). It is an important part of traditional Chinese 
medicine, since it is considered an adaptogen, and believed to have characteristics that 
provide protection to the human body from physiological stress (Brekhman and 
Dardymov, 1969; Ang-lee et al, 2001) . Ginseng is consumed as an extracted herb (tea) or 
as dry ground root. There are two main types of ginseng used in traditional Chinese 
medicine: Asian ginseng (Panax ginseng) and American ginseng (Panax quinquefolius) 
(King et al., 2006). The main difference between Asian and American ginseng is in the 
relative concentrations of each of their active ingredients, known as ginsenosides; 
difference that confers them  with opposite effects on the human body, while Asian 
ginseng is considered a stimulant, American ginseng is known for its calming effects 
(Schlag and McIntosh, 2006).  
1.2  American ginseng (Panax quinquefolius) 
American ginseng is cultivated for commercial production mainly in Ontario, Wisconsin 
and British Columbia, with Ontario being the principal Canadian producer (Roy et al., 
2003; Yuk et al., 2013) . Although Asian and American ginseng are the most commonly 
described herbal species used for their pharmacologic effects (Ang-lee et al, 2001; Qi et 
al., 2011; Cui et al., 2017), compared to its Asian counterpart, studies related to American 
ginseng constituents are limited; although there have been recent advances that have the 
objective of understanding the chemistry, pharmacology and function of American 
ginseng (Qi et al., 2011).  
1.3 Ginseng’s active compounds: ginsenosides 
The pharmacological effects of ginseng have been attributed to ginsenosides, which are 
triterpenoid saponin glycosides (Schlag and McIntosh, 2006). Their structure is based on 
a tetracyclic dammarane carbon skeleton with sugars attached through hydroxyl groups at 
C-3 (or C-6) and C-20. Having sugars attached at both ends of the dammarane carbon 
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skeleton makes ginsenosides bidesmosidic, which increases their solubility,  presumably 
affecting their in vivo function (Bernards et al., 2011). There are more than 40 known 
ginsenosides found in ginseng roots, the most common of which are Rb1, Rb2, Rc, and Rd  
(Cheng et al., 2007); these are based on a 3,12,20-trihydroxylated-20(S)-protopanaxadiol 
aglycone with sugars bound to the hydroxyl groups at positions 3 and 20. Ginsenosides 
Rg1 and Re are also common, and are based on a 3,6,12,20-tetrahydroxylated-20(S)-
protopanaxatriol aglycone with sugars bound to the hydroxyl groups at positions 6 and 20 
(Fuzzati et al., 1999) (Figure 1). Ginsenosides can account for up to ~6% of the root dry 
weight (Schlag and McIntosh, 2006). Moreover, ginsenosides are released into the 
rhizosphere soil as root exudates (Yang et al., 2015). 
Ginsenosides are toxic towards a few common pathogens that attack American ginseng, 
as well as other fungi. In vitro studies by  Nicol et al. (2002) showed a clear inhibition of 
the growth of Trichoderma hamatum (a common saprotrophic fungus), and Alternaria 
panax (a foliar pathogen of ginseng). By contrast, a growth stimulatory effect was 
observed when some oomycete pathogens were cultured in the presence of ginsenosides.  
That is, ginsenosides stimulated the growth of some of the most relevant ginseng 
pathogens, including Pythium irregulare, Phytophthora cactorum (Nicol et al., 2003), 
Ilyonectria destructans and Fusarium solani  (Yang et al., 2015).  
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Figure 1. Common ginsenosides of American ginseng. Ginsenoside structure is based 
on the tetracyclic dammarane carbon skeleton shown at the top left. Sugars, mainly 
glucose but also arabinose, are attached through hydroxyl groups at C-3 and C-20 of the 
20-S-protopanaxadiols, and through hydroxyl groups at C-6 and C-20 of the 20-S-
protopanaxatriols (structures and nomenclature based on Teng et al., 2002)  
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1.4 Pythium irregulare: a pathogenic oomycete 
Oomycetes (phylum Oomycota) are eukaryotic organisms, often with a filamentous 
growth habit. Oomycetes were initially classified as fungi because of their morphology, 
such as the formation of hyphae and reproduction by spores, as well as the fact that some 
feed on living and decaying plant material. Fungi and oomycetes comprise the majority 
of eukaryotic plant pathogens (Latijnhouwers et al., 2003). However, significant 
differences exist between fungi and oomycetes (Dean et al., 2014).  Taxonomic analyses 
of phenotypic characteristics as well as sequence comparisons have shown that these two 
groups correspond to different eukaryotic branches (Latijnhouwers et al., 2003). While 
fungi share a common ancestor with animals, oomycetes are phylogenetically related to 
other protists within the Stramenopiles and their closest relatives are  the heterokont 
golden-brown algae (Baldauf et al., 2000). Moreover, due to their biochemical 
differences, such as their different surface molecules that play an important role on plant 
recognition and defence; chemicals used to control fungi are often not effective in the 
inhibition of oomycetes (Hardham, 2007). 
Oomycetes possess tubular hairs on the anterior flagellum of motile spores, cellulosic cell 
walls and are diploid during the majority of their life cycle (Hardham, 2007). Many 
species of the Oomycota are important plant pathogens (Dean et al., 2014).  Plant 
pathogens can be classified as biotrophs, necrotrophs or hemibiotrophs. Biotrophs grow 
and reproduce in living plant tissue; obtaining nutrients by interacting with the living 
cells of their host, some examples are those found within the families Albuginaceae and 
Peronosporaceae and can cause downy mildews and white rusts. Necrotrophs kill the 
host tissue before colonization to feed on its dead cells; Pythium and Aphanomyces are 
the genera that comprise this type of oomycetes. Hemibiotrophs have intermediary 
pathogenic habits, establishing first a biotrophic relationship with their host, whose cells 
die while the infection advances; this infection pattern can be found within the genera 
Phytophtora and Pythium (Agrios, 2005).  
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The genus Pythium belongs to the Pythiaceae (Hendrix and Campbell, 1973), and is well 
known for containing soil-borne plant pathogens that can infect a large range of plants 
(e.g. tulip, carnation, onion, ginseng, wheat, corn, etc.) (Matsumoto et al., 2000). Pythium 
spp. primarily infect the root of the host plant, principally causing seed rot, damping off 
and root rot of seedlings (Martin and Loper, 1999). Mature plants can also be infected, 
showing root necrosis, leading to poor growth and subsequent death (Larkin et al., 1995: 
Martin and Loper, 1999). 
The main survival structures of Pythium spp. are called oospores, which are thick-walled 
sexual spores that can resist desiccation and  survive in soil for extended periods of time, 
without any hosts available or substrates for growth and development (Martin and Loper, 
1999). These oospores show constitutive dormancy (Martin and Loper, 1999), which 
means that they can remain dormant presumably until they can guarantee the presence of 
a host (Isaac, 1992). According to Martin and Loper (1999), this type of dormancy 
benefits the organism by increasing the probability of survival by not allowing many 
propagules to germinate at the same time.   
Dormant propagules can be activated by environmental changes, most likely through 
biochemical modifications to essential components of metabolic pathways or by changes 
to the membrane permeability (Isaac, 1992). Specifically, factors that can influence the 
transition of dormant to germinable oospores are maturity (e.g. freshly harvested vs. older 
oospores) (Adams, 1971), type of substrate (e.g. soil, clay, culture media, etc.)(Lumsden 
and Ayers, 1975;Johnson and Arroyo, 1983), CO2 concentration (Johnson, 1988), 
humidity changes (e.g. wetting and drying) (Lifshitz and Hancock, 1984) and light 
conditions (Johnson, 1988).  
Once activated, Pythium spp. produce asexual reproductive structures, named sporangia, 
at hyphal tips (Martin and Loper, 1999). Germination of sporangia can be  induced by 
chemical stimulants such as amino acids, carbohydrates or other compounds exuded by 
the root or seeds(Lifshtz et al., 1986; Nelson, 1990; Nelson and Craft, 1989). When 
conditions are ideal to initiate germination of propagules, sporangia and oospores 
germinate by producing a germ tube. Some species also produce zoospores, which are 
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induced by nutrients and humidity (Martin and Loper, 1999). These zoospores do not 
have a cell wall; their plasma membrane acts as their outer surface (Hardam and Hyde, 
1997). These structures can achieve motility due to two flagella that emerge along the 
ventral surface of the cell. Zoospores have specific taxic responses that guide them to 
specific areas of the plant (Hardham, 2007). Germinating seeds as well as roots attract 
them; once zoospores reach a root, they adhere, encyst and  germinate to produce a 
penetration peg that penetrates the host cell wall in order to begin colonization by 
saprophytic growth of hyphae in the plant tissue (Hancock, 1977). It is hypothesized that 
once the pathogen has penetrated the host cell it induces changes in host cell organization 
and metabolism in order to obtain nutrients (Birch et al., 2006).  
Specifically, Pythium irregulare is one of the most important ginseng pathogens (Yang et 
al., 2015). It is also considered one of the principal pathogenic species of its genus and 
has a worldwide presence (Matsumoto et al., 2000). It is known to also affect important 
crops such as carrot, celery, lettuce, parsnip, radish, watermelon and bean (Howard et al., 
1994; Martin and Loper, 1999).  
The ability of P. irregulare to infect ginseng is correlated with its ability to partially de-
glycosylate ginsenosides, presumably to generate less toxic products (Ivanov and 
Bernards, 2012). Indeed, the glycosidases (ginsenosidases) involved appear to be induced 
by the presence of ginsenosides, at least in vitro (Neculai et al., 2009). Partial 
deglycosylation of the 20 (S)-protopanaxadiol ginsenosides Rb1, Rb2, Rc, Rd and 
gypenoside XVII, via extracellular ginsenosidases, yields ginsenoside F2, which is 
subsequently partially assimilated by the pathogen (Neculai et al., 2009). These findings 
reveal that ginsenosides may act as chemoattractants or growth regulators in the 
pathosystem between ginseng and P. irregulare.  Treatment of ginseng plant roots with a 
relatively high dose of ginsenosides resulted in a delay in infection by P. irregulare in 
pot-grown plants (Ivanov et al., 2015). Moreover, in in vitro assays, P. irregulare 
appeared to grow differently when it encountered ginsenosides, resulting in enhanced 
aerial mycelial growth. Therefore, it has been hypothesized that ginsenosides may cause a 
modification in P. irregulare’s growth habit, which may ultimately lead to the build-up 
of inoculum, and in this way facilitate infection (Ivanov et al., 2015).  
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1.5 Ginseng replant problem 
The elucidation of the role of ginsenosides in the infection mechanism by P. irregulare is 
of importance, since this interaction may be related to a major issue in commercial 
ginseng production, known as the “replant problem”. That is, new ginseng crops planted 
in previous ginseng gardens, suffer a yield reduction because of a lack of good seedling 
growth and germination, as well as the appearance of severe diseases (Yang et al., 2015). 
This is presumed to be caused by the accumulation of pathogens in previously harvested 
soil (Kernaghan et al., 2007). 
In studies performed in a different species of ginseng (Panax notoginseng, also known as 
Sanqi ginseng), it was hypothesized that the secondary metabolites released to the soil by 
the plant could accumulate and become toxic to new ginseng seedlings replanted in the 
same soil. Since Sanqi ginseng contains at least 20 different ginsenosides, which 
contribute to around 6% of its dry mass, they could be a factor in ginseng replant failure 
(Yang et al., 2015). Seedling emergence as well as its survival rate decreased 
significantly with continuous planting over 3 years. Moreover, ginsenosides were 
identified in the roots and soil, and specifically, ginsenosides R1, Rg1, Re, Rg2 and Rd 
were demonstrated to be toxic impeding seedling emergence, growth and diminishing 
root cell vigor (Yang et al., 2015). Replant disease is complex, and likely involves many 
factors. Nevertheless, any factor than can contribute to the build-up of inoculum in the 
soil can also potentially contribute to the replant problem. The influence on pathogen 
growth of ginsenosides present in ginseng garden soil cannot be ruled out as a 
contributing factor. 
 
1.6 Extracellular glycosidases and the metabolism of ginsenosides 
Many plant species produce antifungal saponins, which are used as a barrier to prevent 
infection by pathogenic fungi (Bowyer et al., 1995). However, some fungal pathogens can 
degrade/metabolise/detoxify such host plant saponins via extracellular enzymes. As an 
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example, Gaeumannomyces graminis, which is a fungus that commonly infects cereals, 
can successfully infect a host containing saponins only if it can produce an extracellular 
saponinase enzyme, denominated avenacinase. Therefore it is suggested that the “saponin-
saponinase” interactions are important to the infection mechanism of some pathogens 
(Bowyer et al., 1995). 
In the case of P. irregulare, it has been hypothesized that its pathogenicity varies 
significantly between different hosts (Harvey et al., 2001). This suggests that different 
plants secrete different secondary metabolites to modify the interaction between the 
pathogen and the host. Nonetheless, the role of extracellular enzymes in oomycete 
infection has not been fully stablished yet (Hardham, 2007). 
Furthermore, ginsenosides are known to be mildly fungitoxic but seem to promote the 
growth of root pathogens (g.e. P. irregulare and Ilyonectria destructans), this happens via 
partial metabolism of ginsenosides using extracellular saponinases (g.e. ginsenosidases). 
Specifically, P. irregulare seems to prefer 20(S)-protopanaxadiol ginsenosides, partially 
metabolizing them and yielding ginsenoside F2, while it does not have the ability to 
metabolize any of the 20(S)-protopanaxatriol ginsenosides (Yousef and Bernards, 2006). 
1.7 Previous work  
In previous studies in the Bernards Lab (University of Western Ontario, London, ON, 
Canada), the metabolism of ginsenosides by P. irregulare during growth, in Czapek-Dox 
minimal medium, was monitored in a time-course manner. Ginsenosides were collected 
over the course of 9 days, and analyzed by liquid chromatography. As time progressed, 
all major protopanaxadiol ginsenosides (i.e., Rb1, Rd and GXVII) decreased, while a new 
compound, later identified as ginsenoside F2, accumulated (Yousef and Bernards, 2006). 
At the same time, it was observed that low concentration of protein was secreted into the 
culture medium by P. irregulare. The secreted proteins were fractionated using gel 
filtration and tested for glycosidase activity. Increasing glycosidase activity was 
measured in two distinct fractions. In contrast, P. irregulare grown in the absence of 
ginsenosides displayed little extracellular glycosidase activity. Subsequent purification of 
the secreted glycosidases yielded two distinct activity peaks. The fractions showing 
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glycosidase activity were then tested for ginsenosidase activity by incubation with a 
crude mixture of ginsenosides and were shown to deglycosylate ginsenosides. One 
purified fraction was enriched in (12) glycosidase activity, while the another was 
enriched in (16) activity. In other words, the fractions that corresponded to the first 
activity peak had the ability to deglycosylate ginsenoside Rb1, converting it into 
gypenoside XVII, as well as converting Rd into F2. The second activity peak, on the 
other hand, metabolized Rb1 into Rd, and gypenoside XVII into F2 (Figure 2) (Neculai 
et al., 2009). 
  
 
Figure 2 Deglycosylation of ginsenosides mediated by extracellular ginsenosidases 
from Pythium irregulare.  This schematic representation shows the conversion between 
ginsenosides caused by extracellular ginsenosidases (structures and nomenclatures based 
on Yousef and Bernards, 2006).  
10 
 
 
Altogether, three glycosyl hydrolases with ginsenosidase activity were purified from P. 
irregulare culture filtrates. The two distinct glycosidase activities observed were 
categorized as glycosidase 1 (G1) and glycosidase 2 (G2). Electrophoretic analysis 
showed a clear protein band for G1 and two very close bands for G2, suggesting that this 
fraction contains a mixture of two enzymes, denoted as G2/G3 (Neculai et al., 2009). 
SDS-PAGE and gel filtration were used to estimate the molecular weight of the isolated 
enzymes. G1 is a homodimer with two 78 kDa subunits, while G2 and G3 were predicted 
to be 61 and 57 kDa, respectively. Molecular weight (Mr) and Isoelectric Point (pI) 
values of the purified enzymes were found to be on the same range as fungal saponin-
detoxifying glycosidases such as tomatinase (Quidde et al., 1998) and avenacinase 
(Quidde et al.,  1999)  of Botrytis cinerea. However, they were found to be closer in size 
to ginsenoside-metabolizing enzymes from bacteria and plants (i.e. Panax ginseng, 
Bifidobacterium breve and Fusobacterium) (Neculai et al., 2009).  
Purified proteins were excised from gels, digested with trypsin and subjected to LC-
MS/MS-based sequencing. De-novo amino-acid sequence data obtained from 
ginsenosidases G2 and G3 yielded peptides with conserved amino acid regions with 
100% confidence scores for six proteins annotated as β-glycosidases from the P. ultimum 
Genome Database. These sequences were then used to design degenerate primers with the 
objective of amplifying the genes that encode these enzymes, using total cell DNA as 
well as RNA as templates (Ivanov, 2015). This information facilitated the prediction of 
the 780 bp size amplicon obtained by PCR using P. irregulare genomic DNA as template 
and the degenerate primers noted above (Ivanov, 2015).  
To determine the full coding cDNA sequences for the potential glycosidases, RACE 
(Rapid Amplification for cDNA Ends) experiments were performed (Ivanov, 2015). Both 
5’RACE and 3’RACE resulted in amplicons of approximate sizes of 600 bp and 1100 bp, 
respectively; when aligned, the full coding sequence of one putative β-glycosidase 
(1767  bp without introns) was revealed . The predicted protein encoded by the obtained 
sequence, is expected to contain 589 amino acids and has a predicted molecular weight of 
66.14 kDa and a pI of 6.25 (Ivanov, 2015).  
11 
 
 
Homology modeling revealed that the P. irregulare sequence most closely resembled a 
glycosyl hydrolase family 1 type β-glycosidase from wheat (Ivanov, 2015). The 3D 
model, generated using using the Phyr2.0 website and rendered using the Chimera 1.10 
software demonstrated that the predicted protein structure contains glutamine residues 
(Glu 198 and Glu 416) that act as a potential active site where glucose residues may bind. 
The putative β-glycosidase from P. irregulare was denoted PiGH1-x, where the “x” is a 
place-holder pending confirmation of catalytic activity. 
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1.8  Thesis objectives 
Extracellular glycosidases produced by P. irregulare are clearly associated with the 
ability of this organism to infect ginseng. Nevertheless, the specific mechanism remains 
unclear, which is why it is important to further analyse the function of this enzymes in the 
infection mechanism. Therefore, the objectives of the present thesis are: 
1. Cloning and expression of PiGH1-x produced by P. irregulare. 
2. Characterisation of the recombinant PiGH1-x protein with respect to its ability to 
deglycosylate ginsenosides. 
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2 MATERIALS AND METHODS 
All the reagents used in this project were obtained from Sigma-Aldrich, except when 
noted otherwise.  
2.1 Cloning and expression of PiGH1-x 
2.1.1 PCR 
The Polymerase Chain Reaction (PCR) was used in order two amplify the full Open 
Reading Frame (ORF) of PiGH1-x from the stock of a clone generated by Dimitre Ivanov 
(Ivanov, 2015); which was used as a template. New primers were designed to generate 4 
different constructs for protein expression (Table 1, Figure 3), based on the protocol by 
Rahman et al. (2011). A detailed list of primers can be found in Appendix 1. 
The PiGH1-x constructs were amplify using Platinum Taq DNA Polymerase High 
Fidelity (ThermoFisher Scientific) to ensure high specificity. The master mix used was 
composed of 10X High Fidelity PCR buffer, 50 mM MgSO4, 10 mM dNTP mix, 10 µM 
forward primer and 10 µM reverse primer. The PCR program was as follows. The pre-
denaturation stage was first run at 94ºC for 3 min. The next cycle was repeated during 
35 times and consisted of 3 steps: the denaturing step at 94ºC for 45s, the annealing step 
at 54ºC for 45s and the extension at 72ºC for 2:30 min.  Final elongation was run at 72ºC 
for 10 min, and the final hold was set at 4ºC. 
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Table 1 Description and nomenclature of constructs used. 
CONSTRUCT NAME EXPECTED AMPLICON  
5’his 
Size: 1839 bp 
Full PiGH1-x sequence, with a TEV recognition site and a 6× His tag 
attached to the 5’ end.  
short 
Size: 1818 bp 
Truncated PiGH1-x (tPiGH1-x) sequence (signal peptide sequence 
removed) with a TEV recognition site followed by a 6× His tag 
attached to the 5’ end. 
3’his 
Size: 1819 bp 
Full PiGH1-x sequence, with a 6× His tag attached to the 3’ end. 
 
full 
Size 1785 bp 
Full PiGH1-x sequence, without any purification tags. 
   
 
 
Figure 3 Graphic representations of the designed constructs. ORF of the protein is 
shown in light blue, 6×His tag sequence in dark blue and the TEV recognition site in 
orange. All sequences are flanked by NcoI and BamHI restriction sites.  
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2.1.2 Cloning PiGH1-x 
PCR amplification described in section 2.1.1 resulted in amplicons of roughly 1.8 kb 
(corresponding to the full length clone). Bands of the expected size were extracted from 
1% agarose gels using the QIAquick Gel Extraction Kit (Qiagen N.V.) followed by 
cleanup using the QIAquick PCR Purification Kit (Qiagen N.V.), in order to completely 
remove any residual primers. Each of the resulting fragments were ligated into a cloning 
vector pGEM-T Easy, according to the instructions of the manufacturer (Promega Corp. 
Fitchburg, WI, USA). Competent E. coli DH5α cells were then transformed by heat-
shock, per the manufacturer’s instructions (Invitrogen), to incorporate the plasmids 
containing the desired constructs.  
After ampicillin-based selection of transformed E. coli, DNA was extracted using the 
Qiaprep Spin Mini-Prep Kit (Qiagen N.V.). To verify that the correct constructs were 
inserted into the vector, resulting DNA was analyzed using T7 and Sp6 primers in an 
Applied Biosystems 3730 Analyzer at the DNA Sequencing Facility at the London 
Regional Genomics Centre (Robarts Research Institute, London, ON, Canada). Sequence 
verification was performed by aligning the resulting sequences with the expected ORF, 
and sequences for restriction sites and purification tags where applicable, using the 
software DNAMAN Version 6 (Lynnon Corporation). 
 
2.1.3 Recombinant protein expression and purification 
Molecular cloning, expression and purification of recombinant PiGH1-x was initially 
performed in collaboration with Dr. John McCormick (Microbiology and Immunology, 
UWO) using his standard protocol (McCormick and Schlievert, 2003). Briefly, the 
protein genes were cloned into the pET28a plasmid, using PCR to incorporate NcoI and 
BamHI restriction sites through the forward and reverse primers, respectively. The NcoI 
was engineered in a way that allowed an in frame translational fusion with the ATG start 
codon of the target construct (McCormick and Schlievert, 2003). Competent E.coli 
BL21(DE3) cells were transformed by heat shock, according to manufacturer’s 
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instructions (Novagen), and 4 clones were generated, each of them containing one of the 
desired expression cassettes. This E.coli strain carries the DE3 lysogen that encodes the 
T7 RNA polymerase under inducible control by β-D-galactopyranoside (IPTG) 
(McCormick and Schlievert, 2003). 
 
2.1.4 Screening of colonies 
Colonies containing the plasmids of interest were screened by a small-scale induction to 
verify their capability of expressing the desired recombinant protein. For this purpose, 
cultures were grown overnight in 4 mL of LB medium supplemented with 50 µg/mL of 
Kanamycin. Next, 5 µL of the resulting overnight culture were then subcultured into 
5 mL of LB medium with 50 ug/mL of Kanamycin. 
Diluted cultures were grown at 37°C on a shaker at 300 rpm for 2.5 h prior to induction 
using 200 M IPTG and kept in the incubator overnight. For each construct tested, both 
an induced and an uninduced culture were grown.  
The overnight screening cultures were pelleted at 6000 × g for 3 minutes using a tabletop 
centrifuge, and the supernatant was discarded. Next, cells were resuspended in 1 mL 
Hepes buffer (10 mM Hepes, 150 mM NaCl, pH 7.4) and sonicated using a Branson 
Sonifier 450 (30 pulses at output 4 and duty 40%). Samples were then centrifuged in a 
benchtop microcentrifuge at 13000 × g for 2 min (McCormick and Schlievert, 2003).  
The supernatants, containing crude protein extracts, were analyzed on 12% SDS-PAGE 
gels, which were run for 30 min at 40 V followed by 1 h at 100 V in a Bio-Rad 
electrophoresis chamber, according to manufacturer’s instructions. Gels were then stained 
in a staining solution containing 1 g of Coomasie Brilliant Blue dissolved in 1 L of 
destain solution (20% methanol, 10% glacial acetic acid, 70% ddH2O), with light shaking 
for 1 h. Afterwards, the staining solution was removed and gels were soaked in destain 
solution for 2 h to allow the existing protein bands to be visualized.  
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2.1.5 Large-scale induction 
Successfully screened clones were subcultured at a 1:1000 dilution into 300 mL of LB 
medium with 50 ug/mL of Kanamycin and grown at 37°C with shaking at 300 rpm for 
2.5 h. Protein expression was then induced by the addition of 200 M IPTG. Cultures 
were grown overnight prior to protein isolation (McCormick and Schlievert, 2003). 
2.1.6 Extraction under non-denaturing conditions 
Large overnight induced cultures (resulting from full, 5’his, and 3’his) were centrifuged 
in a large centrifuge bottle, using a JLA 16.250 rotor at 8000 × g, and the pellet was 
resuspended in 10 mL of Hepes buffer with 10 µL of DNase I (Thermo Scientific, 
10  mg/mL) and 50 L of chicken egg lysozyme (Sigma, 10 mg/mL). Samples were 
incubated for 1 h at 4°C. An uninduced control was also prepared for each sample, 
following the same method but without addition of IPTG. 
Next, the samples were sonicated for 3 sets using a Branson Sonifier 450 (each set 
consisting of 50 pulses at output 4 and duty 40%). Cellular debris was removed by 
centrifugation for 10 minutes at 12000 × g (using a JA-25.50 rotor) and the supernatant 
was collected as it corresponded to the crude protein extract. Extracts were analyzed by 
SDS-PAGE using 12% gels. 
2.1.7 Extraction under denaturing conditions 
In order to avoid protein aggregation, recombinant versions of PiGH1-x (expressed from 
constructs full, 5’his and 3’his using the method described in section 2.1.1) were 
extracted under denaturing conditions, following the “Urea protocol” provided by the 
Instruction Manual of the ProfinityTM IMAC Resin (Bio-Rad). An uninduced control was 
also prepared for each sample, following the same protocol, but without addition of 
IPTG. 
Briefly, large overnight induced cultures were centrifuged in a large centrifuge bottle, 
using a JLA 16.250 rotor at 8000 × g, and the pellet was resuspended in 10 mL of Lysis 
Buffer (50 mM sodium phosphate, 300 mM NaCl, 5 mM imidazole, Urea 6 M, and 1 mM 
PMSF). After 1 hour of incubation at 4°C the cells were sonicated for 4 sets (each set 
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consisting of 30 pulses at output 4 and duty 40%). The cell suspension was centrifuged at 
12000 × g for 10 minutes using a JA-25.50 rotor, and the pellet was resuspended in 
10 mL of PBS buffer (8M urea, pH 7.5). Protein presence was verified through 
electrophoresis using 12% SDS-PAGE gel. 
2.1.8 6× His-tag Purification 
2.1.8.1 Non-denatured protein extracts 
The recombinant tagged proteins expressed in E. coli BL21 (resulting from the constructs 
denominated: 5’his, short, and 3’his), were passed through a column with ProfinityTM 
IMAC Resin (Bio-Rad) charged with Ni2+ to bind the 6× His-tag. Elution was performed 
using an imidazole gradient from 0-200 mM (Günther et al., 2007).  
The fraction with the highest concentration of imidazole was treated with a recombinant 
auto-inactivation-resistant His7::TEV protease to cleave the His6::rPiGH1-x and 
His6::rtPiGH1-x fusion proteins (Rahman et al., 2011). The aim of this method was to 
separate the purification tag as well as the His7::TEV protease from rPiGH1-x and 
rtPiGH1-x with the use of a second nickel affinity column (McCormick and Schlievert, 
2003). Recombinant protein purity was assessed using a 12% SDS-PAGE gel and protein 
yield quantified using the Quick Start TM Bradford Protein Assay kit.  
2.1.8.2 Denatured protein extracts 
The recombinant tagged proteins expressed in E. coli BL21, resulting from the constructs 
denominated 5’his, and 3’his (as there was not a difference in protein yields between 
constructs, the clone containing the construct short was not used in subsequent analyses 
to avoid activity issues), and extracted using denaturing conditions were passed through a 
column with ProfinityTM IMAC Resin (Bio-Rad) charged with Ni2+, using denaturing 
conditions and following a protocol for on-column refolding as per manual instructions. 
This protocol includes a re-folding step, and is expected to yield a re-natured protein 
upon final elution. 
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2.1.9 Buffer-exchange 
The protein extracts obtained from the extraction described in 2.1.7, as well as the non-
refolded protein from the flow-through samples obtained from method 2.1.8.2, were 
buffer exchanged overnight (i.e. 16 hours), against three changes of 1 L of 10 mM MES 
buffer (pH 6.5), through dialysis using a molecular porous membrane tubing 
(Spectra/Por, 12-14 kDa molecular weight cut-off). 
2.1.10 Western-Blot Analysis 
Western-Blot Analysis was performed in order to detect the affinity tag expressed in the 
protein preparations 3’his and 5’his. This was performed according to the “General 
Protocol for Western Blotting” provided by Bio-Rad, using a conjugated Anti-his (C-
Term)-HRP Antibody (Novex). 
First, a 12% SDS gel was run in order to separate the protein fractions of the samples 
(running parameters as described in previous sections, without the staining process).  
Next, the protein gel was transferred to a nitrocellulose membrane with a pore size of 
0.45 µm (Bio-Rad), which was placed on the running cassette and into the transfer tank. 
Transfer was performed in the cold room overnight at a constant current of 10 mA, 
according to the manufacturer’s instructions. 
Afterwards, the blot was rinsed and stained with Ponceau S staining buffer (0.2% (w/v) 
Ponceau S, 5% glacial acetic acid), rinsed again and followed by incubation with the 
conjugated Anti-his (C-Term)-HRP Antibody in 5% non-fat dried milk, for 3 h in the 
cold room.  
Blots were visualized using the Amersham ECL Western Blotting Detection Reagent (GE 
Healthcare). This was achieved following the manufacturer’s instructions, mixing an 
equal volume of detection solution 1 and detection solution 2, making sure that the total 
volume covered the membrane. Next, the excess buffer was drained and the blot was 
wrapped using plastic wrap. Then, the wrapped blot was placed in an X-ray film cassette 
and a sheet of autoradiography film (Fujifilm, Fuji Medical X-Ray Film, 13×18 cm) was 
placed on top of the membrane. The cassette was exposed for 5 min. 
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The film was developed in the dark room by soaking the film in developing solution 
(Kodak Carestream GBX) for 15 min, followed by submersion in fixer solution for 5 min 
(Kodak Carestream GBX). The film was then rinsed with distilled water and allowed to 
air-dry.  
2.1.11 Gel filtration chromatography 
After extraction following the protocol mentioned in sections 2.1.6 and 2.1.7, the 
recombinant protein extracts (non-denatured and renatured) resulting from the expression 
cassette full, were partially purified using gel filtration chromatography on a Sephacryl S-
200 HR column (GE Healthcare), using 10 mM MES buffer (pH 6.5, containing 100 mM 
KCl) as the mobile phase at a flow rate of 0.5 ml/min. Collection of 1 mL fractions began 
after one hour of elution. 
A preparation containing 1 mg/mL each of Blue Dextran and BSA (bovine serum 
albumin) was also run under the same conditions and used as molecular weight markers. 
Blue Dextran has a high mass (~ 2e6 kDa) and is used to track the void volume of the 
column, while BSA has a molecular mass is of 66.4 kDa (Sigma Aldrich,), and was used 
to determine the expected elution volume for recombinant PiGH1-x. 
2.2 Enzyme activity assays 
2.2.1 Colorimetric Glycosidase Assay 
Protein extracts and fractions obtained from the gel filtration column, were tested for 
glycosidase activity using a colorimetric method based on the use of p-nitrophenyl β-D-
glucopyranoside (pNPG) as substrate. The enzyme preparations were incubated with 
pNPG at 30ºC overnight (reaction mixture contained 90 μL of enzyme preparation in 
10  mM MES buffer pH 6.5 and 10 μL of 50 mM pNPG). The reaction was stopped with 
the addition of 100 μL of 1 M Na2CO3 to enhance color formation. The reaction product, 
p-nitrophenol (pNP), which yielded a yellow solution,  was measured at 420 nm Figure 4 
(Neculai et al., 2009). Successive fractions indicating an activity peak were pooled 
together. Negative controls (90 μL of 10 mM MES buffer pH 6.5 and 10 μL of 50 mM 
pNPG) were used to determine background absorbance at 420 nm. 
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For each gel filtration column run, the pooled protein contained in the 10 fractions 
defining the void volume, as well as the 10 fractions representing the ~ 66 kDa protein 
elution volume were concentrated using an Amicon Ultra-15 Centrifugal Filter Unit 
(Millipore). The concentrated samples were subsequently used for enzyme assay using 
pNPG and ginsenosides. Similarly, the two His-labeled proteins (3’his and 5’his), were 
assayed before and after application to a Ni-column. Enzyme specific activity was 
measured in nanomoles of PNP/h/µg of protein preparation. 
 
Figure 4 Graphic representation of the conversion of pNPG to P-nitrophenol. 
Reaction used to assay for glycosidase activity, when positive the reaction product emits 
a yellow colour which can be measured using spectrophotometry at 420 nm (reaction 
based on description by Neculai (2009)).  
 
2.2.2 Ginsenosidase Assay 
Ginsenosidase activity of induced and uninduced protein preparations, was tested using 
the protopanaxadiol ginsenoside Rb1 as substrate. Enzymatic reaction mixtures 
containing 10 μL of the substrate (2 mg/mL) and 90 μL of the protein solution in 10 mM 
MES buffer (pH 6.5), were incubated at 30ºC overnight. The reaction was stopped with 
the addition of 100 μL of methanol, and the samples centrifuged at top speed in a 
microcentrifuge for 5 minutes.  The reaction products were transferred to LC vials and 
analyzed using High Performance Liquid Chromatography coupled with Mass 
Spectrometry (LC-MS) (Ivanov et al., 2015). For data analysis, extracted ion 
chromatograms were generated using the expected exact mass of Rb1 ([M+Na+]+ at 
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1131.5922 m/z, retention time: 7.7 min), Rd ([M+Na+]+ at 969.5393 m/z, retention time: 
8.4 min) and Gypenoside XVII ([M+Na+]+ at 969.5393 m/z, retention time: 8.6 min). The 
Na+ adducts were generated by adding Na-Acetate (1 mg/L) to the mobile phase. 
Ginsenosidase specific activity was measured in nmol of product/h/mg of protein 
preparation. 
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3 RESULTS AND DISCUSSION 
3.1 Cloning and expression 
3.1.1 PCR 
The desired PiGH1-x constructs (i.e. full, 3’his, 5’his and short), were successfully 
amplified by PCR, cloned into the pGEM-T easy vector, and transferred into E. coli 
DH5α (Figure 5). DNA minipreps from E.coli DH5α clones were prepared, and the 
clones sequenced for verification (Appendices 2-5). Alignment of the resulting 
sequences with the original PiGH1-x sequence, confirmed that the constructs contained 
the desired sequences with 100% identity to the original ORF of the protein of interest, as 
well as the desired restriction sites and tags added for each construct.  
 
3.1.2 Recombinant protein expression and purification 
3.1.2.1 Molecular cloning into expression vector 
Fragments were extracted from verified clones using the NcoI and BamHI restriction 
sites, ligated into the expression vector pET28a, and transferred into E.coli BL21 (DE3) 
cells.  DNA minipreps prepared from each of the designed constructs yielded PCR 
product bands of the correct size (Figure 6). 
 
 
24 
 
 
 
 
Figure 5. Agarose gel analysis of cloned PiGH1-x constructs. A) PCR product of the 
full (1) and 3’his (2) clones.  B) PCR product of the 5’his (1) and short (2) clones. C) Gel 
extracted fragments of full (1) and 3’his (2) constructs. D) Gel extracted fragments of 
5’his (1) and short (2) constructs. E) Inserts full (1) and 3’his (2) ligated into the MCS of 
pGEM-T easy. F) Empty vector pGEM-T easy (1), inserts 5’his (2) and short (3) ligated 
into the MCS of pGEM-T easy. Ladders are marked with an asterisk.  
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Figure 6 Agarose Gel Analysis of minipreps containing PiGH1-x constructs ligated 
into expression vector.  A) Constructs full (1) and 3’his (2) ligated into the MCS of the 
pET28a expression vector. B) Constructs 5’his (1) and short (2) ligated into the MCS of 
the pET28a expression vector.  Ladders are marked with an asterisk. 
 
3.1.3 Screening of colonies 
 
Screening of colonies induced with IPTG for target protein expression demonstrated that 
only colonies harbouring PiGH1-x constructs expressed a protein of the expected size of 
around 66.1 kDa (Figure 7). There was no apparent difference in the expression levels 
among the constructs (i.e., with and without the signal peptide removed), so, in order to 
minimize the number of proteins to process and avoid potential activity issues associated 
with a truncated protein, the short clone was not used for subsequent experiments.  
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Figure 7 SDS PAGE Analysis of small scale protein induction. Proteins expressed by 
E. coli DH5α with (+) and without (-) induction with IPTG. Colonies 1-2, protein 
expressed from the 5’his construct. Colonies 3-4, protein expressed from the short 
construct. Colony 5, protein expressed from the 5’his construct. Colony 6, protein 
expressed from the 3’his construct. Colony 7, protein expressed from the full construct.  
 
3.1.4 Large-scale protein extractions 
Large scale extractions were performed using proteins expressed from 5’his, 3’his and 
full constructs. Both IPTG-induced and non-induced protein extracts (used as controls) 
were prepared. Protein extraction yielded clear protein bands of the expected size (Figure 
8). 
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Figure 8 SDS PAGE Analysis of large-scale expression under non-denaturing and 
denaturing conditions. 1) 3’his 2) Full 3) 5’his. Ladders are marked with an asterisk. 
3.1.5 His-tagged proteins  
3.1.5.1 Western-Blot analysis  
Western Blot analysis was performed on protein extracts expressed from constructs 3’his 
and 5’his (as those are the proteins that contained a 6× His affinity tag) and little or no 
signal was detected using the anti-His antibody (data not shown). A positive control 
(StFAH1-6×His) yielded a strong band, confirming the function of the antibody (data 
not shown). The lack of signal from recombinant PiGH1-x was unexpected, but may have 
resulted from the tag being inaccessible to the antibody in the folded protein.  It has been 
reported that even under denaturing conditions, the folding of a protein can make a 
portion of the tag inaccessible (Debeljak et al., 2006).  
3.1.5.2 Nickel column purification 
Despite the lack of signal from His-tagged recombinant PiGH1-x in Western Blots, 
extracts were passed through a Ni-affinity column. However, when non-denatured protein 
extracts (i.e. 5’his and 3’his) were passed through a nickel affinity column for 
purification, a large proportion of the recombinant protein was recovered in the flow-
through and wash fractions (Figure 9). Presumably, this was due to the 6× His-tag not 
being exposed in a way that it could interact with the nickel in the column. Bornhorst and 
Falke (2000) suggested that moving the affinity tag to the opposite end of the protein 
could improve the ability of the protein to bind to the column. Nonetheless, although both 
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5’his (Figure 9) and 3’his (data not shown) were his-tagged each on an opposite end, 
column binding was unsuccessful.   
 
Figure 9 SDS PAGE Analysis of Ni+2 based purification of the 5’his his-tagged 
protein, non-denaturing conditions. 1) Crude extract 2) Flowthrough 3) Wash 4) 
25  mM Imidazole 5) 50mM Imidazole 6) 100 mM Imidazole 7) 200 mM imidazole. 
Ladder marked with an asterisk. 
 
3.1.5.3 Preliminary enzyme assays 
Crude extracts of 5’his were assayed for glycosidase activity, and very low activity was 
observed (data not shown). Moreover, no ginsenosidase activity was detected. This 
suggested that the addition of the 6× His-tag to the N-terminus may interfere with the 
active site by steric or electrostatic interactions therefore having an impact on the 
catalytic properties of the enzyme (Kurtzman, 2009). 
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3.1.5.4 Denatured His-tagged protein extracts 
Protein extracts (5’his and 3’his) were prepared using denaturing conditions in an attempt 
to expose the 6× His Tag, making it available to be bound to the nickel column. As part 
of the Ni-column purification process, an on-column refolding step was planned. 
However, despite these precautions, the recombinant proteins of ~66 kDa still eluted in 
the flow-through and wash fractions (Figure 10). Consequently, despite the purification 
under denaturing conditions using an urea-based buffer and imidazole as the eluent, 
which can allow for the isolation of biologically active products (Bornhorst and Falke, 
2000), the denaturing process of the samples was not successful on properly exposing the 
6× His Tag. 
 
Figure 10 SDS PAGE Analysis of Ni+2 based purification of the 5’his and His 3 his-
tagged proteins, denaturing conditions. 11 1)Flowthrough 2)Wash 3) 25 mM 
Imidazole 4) 50mM Imidazole 5) 100 mM Imidazole 6) 200 mM imidazole. Ladders 
marked with an asterisk. 
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3.1.6 Non-tagged proteins 
3.1.6.1 Gel Filtration Chromatography 
Since the recombinant PiGH1-x is highly expressed, and Ni-affinity column purification 
was unsuccessful, a partially purified protein preparation was prepared using gel filtration 
chromatography on a Sephacryl S-200 HR column. This column has a separation range of 
5 – 250 kDa, and was expected to separate the recombinant PiGH1-x (~ 66 kDa) from the 
bulk of the other cellular proteins in the extract.  
Partial calibration of the Sephacryl S-200 HR column with Blue Dextran and BSA 
confirmed that the fractions corresponding to the void volume (> 2e6 Mr) eluted between 
70-90 min after the beginning of the run (elution volume between 35-45 mL), while 
fractions corresponding to a size of ~66 kDa after 50-60 mL of elution (Figure 11). 
However, when the protein preparation of the full PiGH1-x recombinant protein was run 
through the Sephacryl S-200 HR column, the largest peak corresponded to the void 
volume (35-44 mL), with another two minor peaks detected: one at between 45-55 mL 
and the other at between 55-70 mL. The peak eluting between 15-25 mL range was 
expected to contain the monomeric form of the full PiGH1-x protein, which was further 
verified using 12% SDS-PAGE electrophoresis (Figure 12). A protein preparation from a 
non-induced culture did not yield any relevant UV trace (Figure 12). 
That the major peak in the UV trace for the Full PiGH1-x recombinant protein run 
through the Sephacryl S-200 HR column coincided with the void volume was a clear 
indication that the majority of the recombinant protein was in an aggregated form. 
Enzyme assays using pNPG as substrate confirmed that both the void volume fractions as 
well as the fractions corresponding to proteins in the 66 kDa Mr range contained 
glycosidase activity. These results suggested that the Full PiGH1-x recombinant protein 
was forming a large aggregate, and helped explain the lack of His-tag recognition by the 
anti-His antibody. It also provided guidance for attempting to isolate the Full PiGH1-x 
recombinant protein under mild denaturing conditions. 
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Figure 11 Calibration UV trace using BSA and Blue Dextran. A) Void volume peak, 
tracked by addition of Blue dextran. B) BSA peak, corresponding to 66 kDa molecular 
weight range. 
 
Furthermore, after buffer exchange, the Full Renatured preparation was also submitted to 
Gel Filtration Chromatography (Figure 12). However, the UV trace did not show any 
significant signal. This outcome suggests a lack of protein in the preparation; which 
might be explained by the fact that renaturation of the protein through dialysis was 
incomplete. Indeed, when the dialysate was centrifuged prior to loading on the Sephacryl 
S-200 HR column, a visible pellet was observed, suggesting that much of the expressed 
protein was in an insoluble form.  
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Figure 12 UV traces and enzyme activity plots of gel filtration chromatography 
fractions. Yellow bars correspond to glycosidase activity measured using the pNPG 
assay, activity is measured in nanomoles of pNP per hour (left Y axis). Blue line 
corresponds to the UV signal from the Gel Filtration Chromatography (right Y axis). In 
inset gel in the panel for the full protein shows the presence of a 66 kDa protein in both 
the void volume fraction (labelled “A”) and 66 kDa fraction (labelled “B”). 
33 
 
 
 
3.1.6.2 Fraction selection 
Figure 12 shows the activity of each fraction obtained from preparation “full” as well as 
its respective UV trace. The Full Non-induced preparation was used as a control to 
measure potential background activity from bacterial glycosidases. Highest activity is 
observed at the largest fractions, corresponding to the void volume; while fractions on the 
66 kDa range also have high glycosidase activity. These fractions were pooled together 
for subsequent experiments and denominated “66 kDa”, as they comprise the molecular 
range where recombinant PiGH1-x is expected to elute. However, when comparing to the 
non-induced control, there was no substantial difference in the pNPG-based activity 
between the “66 kDa” fractions, while there is a clear increase of activity on the fractions 
that correspond to the void volume. These data confirmed that recombinant PiGH1-x 
formed large molecular weight aggregates after expression.  
There was a clear activity peak in the 66 kDa range in the Full Renatured preparation, 
despite the low quantity of protein in the fractions. These resulted from the fact that part 
of the extract remained insoluble and in the form of a pellet when centrifuged before 
submission through Gel Filtration, as described above.  
 
3.2 Enzymatic activity assays 
The nomenclature and the origin of the samples used in the enzymatic activity assays are 
described in Table 2. 
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Table 2 Nomenclature and description of protein preparations for enzyme assays 
 
NAME DESCRIPTION 
Full Void 
Volume 
rPiGH1-x expressed from full construct. Fractions which eluted 
between 15-44 mL from gel filtration chromatography, corresponding 
to the void volume.  
Full 66 kDa rPiGH1-x expressed from full construct. Fractions from the 45-55 mL 
range resulting from gel filtration chromatography. 
Full 
Renatured 
Void Volume 
rPiGH1-x expressed from full construct and extracted under 
denaturing conditions, renatured by buffer exchange. Fractions which 
eluted between 15-44 mL from gel filtration chromatography, 
corresponding to the void volume. 
Full 
Renatured 66 
kDa 
rPiGH1-x expressed from full construct and extracted under 
denaturing conditions, renatured by buffer exchange. Fractions from 
the 45-55 mL range resulting from gel filtration chromatography. 
Full Non-
induced Void 
Volume 
Protein extract from cultures of cells containing full construct, Non-
induced protein expression. Fractions which eluted between 15-44 mL 
from gel filtration chromatography, corresponding to the void volume. 
Full Non-
induced 66 
kDa 
Protein extract from cultures of cells containing full construct, Non-
induced protein expression. Fractions from the 45-55 mL range 
resulting from gel filtration chromatography. 
3’his Non-
induced 
Protein extract from cultures of cells containing 3’his construct, Non-
induced protein expression.  
3’his Induced rPiGH1-x expressed from 3’his construct. 
3’his 
Renatured 
rPiGH1-x from 3’his construct, recovered from the flowthrough 
fraction eluted from the nickel affinity column (denaturing 
conditions). Sample was renatured under the same conditions 
mentioned in section 2.1.9. 
5’his Non-
induced 
Protein extract from cultures of cells containing 5’his construct, Non-
induced protein expression. 
5’his Induced rPiGH1-x expressed from 5’his construct. 
5’his 
Renatured 
rPiGH1-x from 5’his construct, recovered from the flowthrough 
fraction eluted from the nickel affinity column (denaturing 
conditions). Sample was renatured under the same conditions 
mentioned in section 2.1.9. 
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3.2.1 Glycosidase Activity Assay 
 
Pooled fractions from the various Sephacryl column runs were tested for glycosidase 
activity using the pNPG colorimetric assay (Table 3). One-way ANOVA (p-value of 
0.05) with Sidak’s post hoc test were used to assess whether activity detected in induced 
protein extract samples was significantly different from the equivalent fractions collected 
for non-induced controls of the same construct. This analysis showed that all induced 
protein preparations had greater glycosidase activity than those from non-induced 
cultures, supporting the conclusion that the recombinant PiGH1-x protein expressed in 
induced cultures is a glycosidase.  
The Full Void Volume sample had less activity than the 66 kDa fraction for the same 
protein preparation, suggesting that the aggregated protein was compromised in terms of 
catalytic activity.  
Furthermore, although protein yields in the Full Renatured preparation were very low, 
glycosidase activity was observed at the expected molecular weight. And, although 
activity appears to be higher than in the Non-induced control, this difference is not 
statistically significant.  
In addition, 3’his and 5’his Renatured preparations did not show any glycosidase activity, 
which means that the denaturing conditions used for their extraction were too harsh and 
did not allow proper refolding, causing structural changes which inhibited the enzyme 
activity. On the other hand, 3’his Induced and 5’his Induced, which were prepared from 
crude extracts did show significant glycosidase activity when compared to their 
respective Non-induced controls.  
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Table 3 Glycosidase activity of protein preparations. Enzyme specific activity of 
protein preparations, measured in nmol of PNP/h/µg of protein preparation. Preparation 
“full void volume non-induced” was used as a control for samples “full void volume” and 
“full renatured void volume”; “full 66kDa non-induced” was used as a control for “full 
66 kDa” and “full renatured 66 kDa”; “3’his non-induced” was used as a control for 
“3’his induced” and “3’his renatured”; “5’his non-induced” was used as a control for 
“5’his induced” and “5’his renatured”. Values statistically significant different against 
their control are presented in bolded numbers, while those which represent a statistically 
significant increase in activity (relative to their respective control) are marked with an 
asterisk. 
 
Treatment 
Non-induced 
control 
Induced enzyme  
Full Void Volume 0.40 ± 0.03 0.59 ± 0.01* 
Full Renatured 
Void Volume 
0.40 ± 0.03 <0.01*   
Full 66 kDa 0.10 ± 0.01 0.98 ± 0.01* 
Full Renatured 66 
kDa 
0.10 ± 0.01 0.24 ± 0.01 
3’his Induced 0.38 ±0.02 0.98 ± 0.08* 
3’his Renatured 0.38 ±0.02 0.01 ± 0.01* 
5’his Induced 0.02 ± 0.01 0.31 ± 0.10* 
5’his Renatured 0.02 ± 0.01 0.01 ± 0.01 
3.2.2 Ginsenosidase activity 
For ginsenosidase activity measurements, pooled fractions were incubated with a 
preparation of ginsenoside Rb1, and analysed by LC-MS. Extracted ion chromatograms 
(EICs) generated for the expected products (969.5399 m/z for Rd and Gypenoside XVII, 
and 807.4871 m/z for F2) revealed that in some fractions, Rb1 was converted into 
ginsenosides Rd as well as Gypenoside XVII.  One-way ANOVA (p-value of 0.05) with 
Sidak’s post hoc test were used to evaluate conversion to Rd and conversion to 
Gypenoside XVII, comparisons were made to assess whether activity detected in induced 
protein extract samples was significantly different from the equivalent fractions collected 
for Non-induced controls of the same construct. (Figure 13, Table 4). This means that 
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recombinant PiGH1-x has the ability to partially deglycosylate Rb1, not only via (12) 
glycosidase activity, as initially proposed (Ivanov, 2015), but also via (16) 
glycosidase activity (Table 5). However, there was no F2 formation, which would have 
indicated both (12) and (16) glycosidase activity acting on the same Rb1 
substrate.  
The fact that significant ginsenosidase activity was detected in the Full Void Volume 
sample, confirmed the initial conclusion that the recombinant protein was aggregating 
and eluting as a high molecular fraction. Moreover, since higher activity was measured in 
the Full Renatured Sample, it can be concluded that the aggregated protein does not have 
as much activity as it would in its monomeric form.  
Although the pNPG-based activity of the Full Renatured 66 kDa sample was not 
statistically significant from other glycosidase preparations (Table 3), this preparation 
had significantly higher ginsenosidase activity than in the corresponding non-induced 
preparation (Table 4). In the case of the Full Renatured 66 kDa sample, the background 
protein composition may have been modified. Moreover, a part of the sample was lost 
during the concentration process. Since the ginsenosidase activity of the Full Renatured 
66 kDa sample is statistically significant, this could indicate that the glycosidase activity 
observed comes mainly from rPiGH1-x.  
 
Figure 13 Raw EIC traces. EIC (Extracted Ion Chromatograms) @ 969.5399 m/z. LC-
MS detection of ionic abundance of reaction products. First peak (8.4 min) corresponds to 
Rd. Second peak (8.6 min) corresponds to GXVII. Black (D) Mock assay. Dark Blue (C) 
Full Non-induced Void Volume. Light Blue (E) Full Non-induced 66kDa. Dark Red (A) 
Full induced Void Volume. Light Red (B) Full induced 66kDa. 
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Table 4 Ginsenosidase activity of protein preparations. Measured in nmol of 
product/h/mg of protein preparation. Preparation Full Void Volume Non-induced was 
used as a control for samples Full Void Volume and Full Renatured Void Volume; Full 
66kDa Non-induced was used as a control for Full 66 kDa and Full Renatured 66 kDa; 
3’his Non-induced was used as a control for 3’his Induced and 3’his Renatured; 5’his 
Non-induced was used as a control for 5’his Induced and 5’his Renatured. Values 
statistically significant different against their control are presented in bolded numbers, 
while those which represent a statistically significant increase in activity are marked with 
an asterisk. 
 
Reaction 
Product 
Treatment Non-induced control Induced Enzyme 
Rd 
Full Void Volume 3.92 ± 0.15 17.23 ± 0.40* 
Full Renatured Void 
Volume 
3.92 ± 0.15 4.10 ± 0.36 
Full 66 kDa 1.52 ± 0.02 1.01 ± 0.04 
Full Renatured 66 kDa 1.52 ± 0.02 37.99 ± 3.45* 
3’his Induced 0.75 ± 0.01 10.13 ± 1.42* 
3’his Renatured 0.75 ± 0.01 0.21 ± 0.01 
5’his Induced <0.01 <0.01 
5’his Renatured <0.01 <0.01 
GXVII 
Full Void Volume 3.15 ± 0.21 19.11 ± 0.12* 
Full Renatured Void 
Volume 
3.15 ± 0.21 7.55 ± 0.46 
Full 66 kDa <0.01 13.06 ± 0.18* 
Full Renatured 66 kDa <0.01 30.54 ± 3.12* 
3’his Induced 4.63 ± 0.46 13.17 ± 0.95* 
3’his Renatured 4.63 ± 0.46 2.34 ± 0.05 
5’his Induced 1.16 ± 0.03 1.84 ± 0.12 
5’his Renatured 1.16 ± 0.03 1.22 ± 0.09 
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Table 5 Summary of resulting Glycosidase activity based on substrate conversion. 
Conversion of Ginsenoside Rb1 to Rd demonstrates (12) glycosidase activity, while 
conversion of Ginsenoside Rb1 to GXVII represents (16) activity. 
Treatment Glycosidase activity 
Full Void Volume (12) and (16) 
Full Renatured Void 
Volume No 
Full 66 kDa (12) 
Full Renatured 66 kDa  (12) and (16), 
3’his Induced (12) and (16), 
3’his Renatured No 
5’his Induced No 
5’his Renatured No 
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4 GENERAL DISCUSSION 
The objective of this study was to clone and express the recombinant protein PiGH1-x, 
from the sequence obtained by Ivanov (2015). Furthermore, this work aimed to test the 
ability of the PiGH1-x to deglycosylate ginsenosides. The protein expressed proved to be 
of the expected size of around 66.1 kDa (Ivanov, 2015). 
Protein expression was achieved using E.coli DH5α transformed with the expression 
plasmid pET28a containing the PiGH1-x ORF. Using gel filtration chromatography, it 
was demonstrated that most of the protein formed aggregates during the expression 
process. This issue may be due to the fact that bacteria do not have the capacity to 
perform post-translational modifications by chaperones and proteases, which in many 
cases are needed to achieve ideal eukaryotic protein function (Allen et al., 1992). 
Additionally, high-level protein production and therefore accumulation, can result in the 
formation of intracellular electron-dense protein aggregates best known as inclusion 
bodies (Allen et al., 1992). These bacterial inclusion bodies are the result of an imbalance 
between protein deposition and release, usually generated by the failure in folding or 
degradation of misfolded polypeptides (Villaverde and Carrió, 2003). This phenomenon 
may be avoided by heterologous expression in a eukaryotic organism, such as 
Komagataella phaffii, which is a well characterised organism for heterologous expression 
of recombinant proteins (Ahmad et al., 2014) (previously known as Pichia pastoris 
(Kurtzman, 2009)).  
Even though the aggregated protein contained in the “void volume fractions” (“full” and 
“full renatured”) had reduced functionality, these fractions could deglycosylate 
ginsenoside Rb1, converting it into Rd as well as into Gypenoside XVII, suggesting that 
there are both (12) and (16) glycosidase activities in these fractions. The same 
pattern of ginsenosidase activity, albeit at much lower levels, was observed for both of 
the 5’his and 3’his constructs in crude extracts.  
In the case of the Gel Filtration Chromatography fractions corresponding to 66 kDa 
proteins, the “Full” protein generated Gypenoside XVII, demonstrating only (12) 
glycosidase activity as initially hypothesized (Ivanov, 2015). In contrast, when subjected 
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to the denaturing/renaturing, process the “full renatured” sample demonstrated both 
(12) and (16) glycosidase activities. It is possible that the denaturing/renaturing 
process modified the protein active site, conferring (16) glycosidase activity.  
The fact that recombinant PiGH1-x has ginsenosidase activity supports the hypothesis 
that this enzyme has a role in the selective deglycosylation of the 20(S)-protopanaxadiol 
ginsenoside Rb1 by P. irregulare (Yousef and Bernards, 2006). Most likely, the organism 
uses PiGH1-x to partially degrade ginsenosides, which the ginseng plant uses as a barrier 
to prevent infection by other pathogens (Bowyer et al., 1995). Furthermore, ginsenosides 
can promote the growth of P. irregulare (Yousef and Bernards, 2006), which may happen 
via the partial metabolism of ginsenosides. If this occurs in the field, it may allow 
P. irregulare to accumulate inoculum and therefore facilitate the infection process in 
subsequent ginseng crops.  Additionally, the fact that the protein extracts used as the 
starting material in the prediction of the sequence of PiGH1-x were expressed by 
P. irregulare when exposed to ginsenosides  (Neculai et al., 2009), further supports the 
idea that this enzyme has a role in the pathogenicity of the microorganism against 
ginseng. 
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5 CONCLUSION AND FUTURE RECOMMENDATIONS  
A recombinant PiGH1-x protein was highly expressed in a heterologous (E. coli) system, 
although the process still needs optimization. Specifically, the production of high levels 
of recombinant PiGH1-x in E.coli DH5α resulted in protein aggregates, possibly due to a 
lack of post-translational modifications. Therefore, recombinant expression in a different 
organism with the capability to produce a correctly folded protein, is needed in order to 
obtain a recombinant protein with the correct structure.  
Nonetheless, even though the ideal protein conformation was not achieved, the (12) 
ginsenosidase activity of recombinant PiGH1-x was demonstrated, as it retained part of 
its catalytic properties. Remarkably, when recombinant PiGH1-x was extracted under 
denaturing conditions, and subsequently renatured, both (12) and (16) 
ginsenosidase activities were observed. Further enzyme assays using a “correctly” folded 
recombinant protein would be needed to confirm its glycosidase specificity ((12), 
(16) or both), which will allow the substitution of the place-holder “x” in the name of 
the protein with the number that corresponds to its specific catalytic activity. 
Confirmation that the protein sequence obtained by (Neculai et al., 2009) corresponds to 
a ginsenosidase, as well as the steps taken into the optimization of its expression as a 
recombinant protein, are important steps in elucidating the role of extracellular 
glycosidases of P. irregulare in its pathogenicity towards ginseng. Optimization of both 
the protein induction and its subsequent purification are required to obtain sufficient 
protein for full characterization.  
Enzyme kinetic parameters (i.e. Vmax and KM), should be determined to further 
characterise the enzyme. Moreover, additional enzyme assays should be performed using 
different substrates (e.g. other saponins) to evaluate the ability of PiGH1-x to 
deglycosylate other molecules. This knowledge would provide a better idea of how this 
protein works, therefore allowing to better elucidate its mechanism of action.  
43 
 
 
Additionally, it would be a key step to measure the induced expression of the protein, at 
the gene level, in response to treatment of P.irregulare culture with ginsenosides. This 
would confirm that PiGH1-x is expressed by the organism when exposed to ginseng, as 
part of its infection mechanism.  
Knowledge of the specific mechanisms that confer the pathogenicity of an organism 
makes it more probable to succeed in the suppression of diseases, as it allows a better 
design of controlling agents and processes (Martin and Loper, 1999). Therefore, in order 
to solve some of the current agronomical issues related to the production of American 
ginseng, such as the re-plant problem, it is of great importance to continue studying all of 
the pieces that play a role on its infection by P. irregulare. 
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7 APPENDICES 
 
Appendix 1 List of primers 
full primers 
Forward 
5'-TTTCCATGGATGAAGTGTCTGCAACTG-3' 
                NcoI   PiGH1-x ORF 
Reverse 
5'-CCCGGATCCTTACTGTCCACGCACGAG-3' 
                BamHI    *                PiGH1-x ORF  
3’his primers 
Forward 
5'-TTTCCATGGATGAAGTGTCTGCAACTG-3' 
                NcoI   PiGH1-x ORF 
Reverse 
5'-
CCCGGATCCTTAGCCGCTGCTGGATGATGATGATGATGGCTGCTGCCTGTCCACGCACGAG-
3' 
          BamHI    *                                6× His                                           PiGH1-x ORF  
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5’his primers 
Forward 
5'-
TTTCCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCGAAAACTTG
TATTTCCAAAGTATGAAGTGTCTGCAACTG-3' 
NcoI    6× His    Tev Site  PiGH1-x 
ORF 
Reverse 
5'-CCCGGATCCTTACTGTCCACGCACGAG-3' 
                BamHI    *                PiGH1-x ORF  
short primers 
Forward 
5'-
TTTCCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCGAAAACTTG
TATTTCCAAAGTAGCGCTGTCGTCACCA-3' 
 NcoI    6× His    Tev Site  tPiGH1-x 
ORF 
Reverse 
5'-CCCGGATCCTTACTGTCCACGCACGAG-3' 
                BamHI    *                PiGH1-x ORF  
52 
 
 
 
Appendix 2 Sequence alignment of full 
Fast alignment of DNA sequences pigh1x.seq and full.seq 
 
Ktuple=2  Gap_penalty=7 
 
Upper line: pigh1x.seq, from 1 to 1769 
Lower line: full.seq, from 10 to 1778 
 
pigh1x.seq:full.seq identity= 100.00%(1770/1770) gap=0.51%(9/1779) 
1    .........ATGAAGTGTCTGCAACTGCTTCTGGCTGGCGTCTCGGCCGTGCTCGCGACT 
              ||||||||||||||||||||||||||||||||||||||||||||||||||| 
1    TTTCCATGGATGAAGTGTCTGCAACTGCTTCTGGCTGGCGTCTCGGCCGTGCTCGCGACT 
 
52   GTGAGTGCGAGCGCTGTCGTCACCACCTCCGCGAGTGCCAAGCGCTGCTTCCCGGACGAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
61   GTGAGTGCGAGCGCTGTCGTCACCACCTCCGCGAGTGCCAAGCGCTGCTTCCCGGACGAC 
 
112  TTCCTCTTTGGCTCTGCCACCGCCGCATACCAAGTGGAGGGCGCTTGGAACGAGACCGGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
121  TTCCTCTTTGGCTCTGCCACCGCCGCATACCAAGTGGAGGGCGCTTGGAACGAGACCGGC 
 
172  CGAACGCCGTCAATCTGGGACGACTTCTGTCGCGAGAAGCCCGGTCTTCAGTGCTCGAAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
181  CGAACGCCGTCAATCTGGGACGACTTCTGTCGCGAGAAGCCCGGTCTTCAGTGCTCGAAC 
 
232  GTCGCCGACGACTTCTACCACCGGTACGTGAGCGACATCCAGACGATGGTCGACTCGGGA 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
241  GTCGCCGACGACTTCTACCACCGGTACGTGAGCGACATCCAGACGATGGTCGACTCGGGA 
 
292  TTGGACTCGTTCCGCTTCAGCATCTCCTGGTCGCGCGCCATGAACTGGGACCCTGCGACC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
301  TTGGACTCGTTCCGCTTCAGCATCTCCTGGTCGCGCGCCATGAACTGGGACCCTGCGACC 
 
352  AAGAAGATGAAGCCCAACCCGCAAGGCATCGCCTTCTACCACGCGCTCATCGACGAGCTC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
361  AAGAAGATGAAGCCCAACCCGCAAGGCATCGCCTTCTACCACGCGCTCATCGACGAGCTC 
 
412  AAGCGCAACAATATCGTGCCGATCTTGACGCTCTACCACTGGGACCTCCCGAGCGAATTG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
421  AAGCGCAACAATATCGTGCCGATCTTGACGCTCTACCACTGGGACCTCCCGAGCGAATTG 
 
472  CACAGTGAGCTCAAGCCGCAGGGTTGGCTCAACCGCGAGATCATCGATCACTTCGTTGAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
481  CACAGTGAGCTCAAGCCGCAGGGTTGGCTCAACCGCGAGATCATCGATCACTTCGTTGAG 
 
532  TACTCGGAGCTCATATTCAACGAGTTTGGCAAGAAGGTGGACATGTGGACGACGTTCAAT 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
541  TACTCGGAGCTCATATTCAACGAGTTTGGCAAGAAGGTGGACATGTGGACGACGTTCAAT 
 
592  GAGCCGCTGTCGTTCGTCTCCCAGGGCTACGCAACGGGCATGTCGGCTCCAGGATACACC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
601  GAGCCGCTGTCGTTCGTCTCCCAGGGCTACGCAACGGGCATGTCGGCTCCAGGATACACC 
 
53 
 
 
652  AACTCCAAGACGAACGCGTACGTTGTCGCGCACAACGTGCTGCTCTCGCACGGCAAGGCG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
661  AACTCCAAGACGAACGCGTACGTTGTCGCGCACAACGTGCTGCTCTCGCACGGCAAGGCG 
 
712  GTGCAGCGCTTCCGCGAGCTCAAGAAGAGCAACGTCGTCCATGAGAAGGCGCGCATCGGT 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
721  GTGCAGCGCTTCCGCGAGCTCAAGAAGAGCAACGTCGTCCATGAGAAGGCGCGCATCGGT 
 
772  ATCGTGATTGTCGACCACTTCTACTACCCTCTCGACCCGAGCAACCCGCGCGACGTCATT 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
781  ATCGTGATTGTCGACCACTTCTACTACCCTCTCGACCCGAGCAACCCGCGCGACGTCATT 
 
832  GCGGCTGAGCGCGCGATCCAGTTTGGATTCGGCTGGTTCTTCATTCCCATAGTGACTGGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
841  GCGGCTGAGCGCGCGATCCAGTTTGGATTCGGCTGGTTCTTCATTCCCATAGTGACTGGC 
 
892  AAGTATCCAGACGTGATGCGCGAACGTGTCGGTGACCGCCTGCCAGAGTTCACGGCGGAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
901  AAGTATCCAGACGTGATGCGCGAACGTGTCGGTGACCGCCTGCCAGAGTTCACGGCGGAG 
 
952  GAAGCTGCGATGGTAAAGGACTCGTACGACCTCTTCATGCTCAACCACTACTCATCCCAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
961  GAAGCTGCGATGGTAAAGGACTCGTACGACCTCTTCATGCTCAACCACTACTCATCCCAC 
 
1012 ACTGTGACGGACTGCGACTCCGAAACGTCGCTCGTCAAGTGCAGCGATTTGTCCCTCGGA 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1021 ACTGTGACGGACTGCGACTCCGAAACGTCGCTCGTCAAGTGCAGCGATTTGTCCCTCGGA 
 
1072 TGGGAACAGGATATGGGCGTCGACAGTACGCGTGCGCCAGACGGTGCGCGTCTGTCCAGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1081 TGGGAACAGGATATGGGCGTCGACAGTACGCGTGCGCCAGACGGTGCGCGTCTGTCCAGC 
 
1132 AAGAACAGCCTCGGCGAGTACAACTGCAAGTGGTTCACGGGATACCCGGCAGGCTACCTG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1141 AAGAACAGCCTCGGCGAGTACAACTGCAAGTGGTTCACGGGATACCCGGCAGGCTACCTG 
 
1192 GAAATGATCAAGTGGATGCACAAGTACAACACAAAGGCGGACATCTTACTCACCGAGAAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1201 GAAATGATCAAGTGGATGCACAAGTACAACACAAAGGCGGACATCTTACTCACCGAGAAC 
 
1252 GGCTGGTGCGGCAACGAGACCATCGACAACCAGGACCAACTCTGGTACTTCCAGAGCTAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1261 GGCTGGTGCGGCAACGAGACCATCGACAACCAGGACCAACTCTGGTACTTCCAGAGCTAC 
 
1312 ATCGGCGAAGTCTACAAGGCGATCAACGAACTCAAGATCCCCATCATTGGGTACACTGCG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1321 ATCGGCGAAGTCTACAAGGCGATCAACGAACTCAAGATCCCCATCATTGGGTACACTGCG 
 
1372 TGGTCGTTCATGGACAACTACGAGTGGGGCTCATTCAAGCCTCGCTTTGGACTCTACTAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1381 TGGTCGTTCATGGACAACTACGAGTGGGGCTCATTCAAGCCTCGCTTTGGACTCTACTAC 
 
1432 GTCAATTTCACGTCCGAGACCGGCAAGGCGGATGAGGTCACCCCAGGATCAAACGCCTTG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1441 GTCAATTTCACGTCCGAGACCGGCAAGGCGGATGAGGTCACCCCAGGATCAAACGCCTTG 
 
1492 GCACGCATCCCACGTCCTGCGGCCAAATGGTACGCGCAAGTGGCGAAGACCAAGTGCCTC 
54 
 
 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1501 GCACGCATCCCACGTCCTGCGGCCAAATGGTACGCGCAAGTGGCGAAGACCAAGTGCCTC 
 
1552 GACGGCTTTGAGATTGAAGGCGTGCCAGTCTTGGCAGGAGTCAGCGACGTTACTGGTACC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1561 GACGGCTTTGAGATTGAAGGCGTGCCAGTCTTGGCAGGAGTCAGCGACGTTACTGGTACC 
 
1612 AGCTCTGGCAGCAGCTTTAAGACGTTCGCACTCTGGGGGCTGGTGCTGGGTGTTGTTGTC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1621 AGCTCTGGCAGCAGCTTTAAGACGTTCGCACTCTGGGGGCTGGTGCTGGGTGTTGTTGTC 
 
1672 GGCGTACCAGCGATCGCTTTCTTTGTCAAGAGCCGTCGCTCTCGTCAGAGCTCGCTGCTC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1681 GGCGTACCAGCGATCGCTTTCTTTGTCAAGAGCCGTCGCTCTCGTCAGAGCTCGCTGCTC 
 
1732 CGCGCGGGCGAGAACACGCCGCTCGTGCGTGGACAGTAA 
     |||||||||||||||||||||||||||||||||||||||          
1741 CGCGCGGGCGAGAACACGCCGCTCGTGCGTGGACAGTAAGGATCCGGG 
 
Appendix 3 Sequence alignment of 3’his 
Fast alignment of DNA sequences pigh1x.seq and 3’his.seq 
 
Ktuple=2  Gap_penalty=7 
 
Upper line: pigh1x.seq, from 1 to 1767 
Lower line: 3’his.seq, from 10 to 1776 
 
pigh1x.seq:3’his.seq identity= 99.89%(1768/1770) gap=0.51%(9/1779) 
1    .........ATGAAGTGTCTGCAACTGCTTCTGGCTGGCGTCTCGGCCGTGCTCGCGACT 
              ||||||||||||||||||||||||||||||||||||||||||||||||||| 
1    TTTCCATGGATGAAGTGTCTGCAACTGCTTCTGGCTGGCGTCTCGGCCGTGCTCGCGACT 
 
52   GTGAGTGCGAGCGCTGTCGTCACCACCTCCGCGAGTGCCAAGCGCTGCTTCCCGGACGAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
61   GTGAGTGCGAGCGCTGTCGTCACCACCTCCGCGAGTGCCAAGCGCTGCTTCCCGGACGAC 
 
112  TTCCTCTTTGGCTCTGCCACCGCCGCATACCAAGTGGAGGGCGCTTGGAACGAGACCGGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
121  TTCCTCTTTGGCTCTGCCACCGCCGCATACCAAGTGGAGGGCGCTTGGAACGAGACCGGC 
 
172  CGAACGCCGTCAATCTGGGACGACTTCTGTCGCGAGAAGCCCGGTCTTCAGTGCTCGAAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
181  CGAACGCCGTCAATCTGGGACGACTTCTGTCGCGAGAAGCCCGGTCTTCAGTGCTCGAAC 
 
232  GTCGCCGACGACTTCTACCACCGGTACGTGAGCGACATCCAGACGATGGTCGACTCGGGA 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
241  GTCGCCGACGACTTCTACCACCGGTACGTGAGCGACATCCAGACGATGGTCGACTCGGGA 
 
292  TTGGACTCGTTCCGCTTCAGCATCTCCTGGTCGCGCGCCATGAACTGGGACCCTGCGACC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
301  TTGGACTCGTTCCGCTTCAGCATCTCCTGGTCGCGCGCCATGAACTGGGACCCTGCGACC 
 
352  AAGAAGATGAAGCCCAACCCGCAAGGCATCGCCTTCTACCACGCGCTCATCGACGAGCTC 
55 
 
 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
361  AAGAAGATGAAGCCCAACCCGCAAGGCATCGCCTTCTACCACGCGCTCATCGACGAGCTC 
 
412  AAGCGCAACAATATCGTGCCGATCTTGACGCTCTACCACTGGGACCTCCCGAGCGAATTG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
421  AAGCGCAACAATATCGTGCCGATCTTGACGCTCTACCACTGGGACCTCCCGAGCGAATTG 
 
472  CACAGTGAGCTCAAGCCGCAGGGTTGGCTCAACCGCGAGATCATCGATCACTTCGTTGAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
481  CACAGTGAGCTCAAGCCGCAGGGTTGGCTCAACCGCGAGATCATCGATCACTTCGTTGAG 
 
532  TACTCGGAGCTCATATTCAACGAGTTTGGCAAGAAGGTGGACATGTGGACGACGTTCAAT 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
541  TACTCGGAGCTCATATTCAACGAGTTTGGCAAGAAGGTGGACATGTGGACGACGTTCAAT 
 
592  GAGCCGCTGTCGTTCGTCTCCCAGGGCTACGCAACGGGCATGTCGGCTCCAGGATACACC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
601  GAGCCGCTGTCGTTCGTCTCCCAGGGCTACGCAACGGGCATGTCGGCTCCAGGATACACC 
 
652  AACTCCAAGACGAACGCGTACGTTGTCGCGCACAACGTGCTGCTCTCGCACGGCAAGGCG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
661  AACTCCAAGACGAACGCGTACGTTGTCGCGCACAACGTGCTGCTCTCGCACGGCAAGGCG 
 
712  GTGCAGCGCTTCCGCGAGCTCAAGAAGAGCAACGTCGTCCATGAGAAGGCGCGCATCGGT 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
721  GTGCAGCGCTTCCGCGAGCTCAAGAAGAGCAACGTCGTCCATGAGAAGGCGCGCATCGGT 
 
772  ATCGTGATTGTCGACCACTTCTACTACCCTCTCGACCCGAGCAACCCGCGCGACGTCATT 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
781  ATCGTGATTGTCGACCACTTCTACTACCCTCTCGACCCGAGCAACCCGCGCGACGTCATT 
 
832  GCGGCTGAGCGCGCGATCCAGTTTGGATTCGGCTGGTTCTTCATTCCCATAGTGACTGGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
841  GCGGCTGAGCGCGCGATCCAGTTTGGATTCGGCTGGTTCTTCATTCCCATAGTGACTGGC 
 
892  AAGTATCCAGACGTGATGCGCGAACGTGTCGGTGACCGCCTGCCAGAGTTCACGGCGGAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
901  AAGTATCCAGACGTGATGCGCGAACGTGTCGGTGACCGCCTGCCAGAGTTCACGGCGGAG 
 
952  GAAGCTGCGATGGTAAAGGACTCGTACGACCTCTTCATGCTCAACCACTACTCATCCCAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
961  GAAGCTGCGATGGTAAAGGACTCGTACGACCTCTTCATGCTCAACCACTACTCATCCCAC 
 
1012 ACTGTGACGGACTGCGACTCCGAAACGTCGCTCGTCAAGTGCAGCGATTTGTCCCTCGGA 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1021 ACTGTGACGGACTGCGACTCCGAAACGTCGCTCGTCAAGTGCAGCGATTTGTCCCTCGGA 
 
1072 TGGGAACAGGATATGGGCGTCGACAGTACGCGTGCGCCAGACGGTGCGCGTCTGTCCAGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1081 TGGGAACAGGATATGGGCGTCGACAGTACGCGTGCGCCAGACGGTGCGCGTCTGTCCAGC 
 
1132 AAGAACAGCCTCGGCGAGTACAACTGCAAGTGGTTCACGGGATACCCGGCAGGCTACCTG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1141 AAGAACAGCCTCGGCGAGTACAACTGCAAGTGGTTCACGGGATACCCGGCAGGCTACCTG 
 
1192 GAAATGATCAAGTGGATGCACAAGTACAACACAAAGGCGGACATCTTACTCACCGAGAAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
56 
 
 
1201 GAAATGATCAAGTGGATGCACAAGTACAACACAAAGGCGGACATCTTACTCACCGAGAAC 
 
1252 GGCTGGTGCGGCAACGAGACCATCGACAACCAGGACCAACTCTGGTACTTCCAGAGCTAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1261 GGCTGGTGCGGCAACGAGACCATCGACAACCAGGACCAACTCTGGTACTTCCAGAGCTAC 
 
1312 ATCGGCGAAGTCTACAAGGCGATCAACGAACTCAAGATCCCCATCATTGGGTACACTGCG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1321 ATCGGCGAAGTCTACAAGGCGATCAACGAACTCAAGATCCCCATCATTGGGTACACTGCG 
 
1372 TGGTCGTTCATGGACAACTACGAGTGGGGCTCATTCAAGCCTCGCTTTGGACTCTACTAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1381 TGGTCGTTCATGGACAACTACGAGTGGGGCTCATTCAAGCCTCGCTTTGGACTCTACTAC 
 
1432 GTCAATTTCACGTCCGAGACCGGCAAGGCGGATGAGGTCACCCCAGGATCAAACGCCTTG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1441 GTCAATTTCACGTCCGAGACCGGCAAGGCGGATGAGGTCACCCCAGGATCAAACGCCTTG 
 
1492 GCACGCATCCCACGTCCTGCGGCCAAATGGTACGCGCAAGTGGCGAAGACCAAGTGCCTC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1501 GCACGCATCCCACGTCCTGCGGCCAAATGGTACGCGCAAGTGGCGAAGACCAAGTGCCTC 
 
1552 GACGGCTTTGAGATTGAAGGCGTGCCAGTCTTGGCAGGAGTCAGCGACGTTACTGGTACC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1561 GACGGCTTTGAGATTGAAGGCGTGCCAGTCTTGGCAGGAGTCAGCGACGTTACTGGTACC 
 
1612 AGCTCTGGCAGCAGCTTTAAGACGTTCGCACTCTGGGGGCTGGTGCTGGGTGTTGTTGTC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1621 AGCTCTGGCAGCAGCTTTAAGACGTTCGCACTCTGGGGGCTGGTGCTGGGTGTTGTTGTC 
 
1672 GGCGTACCAGCGATCGCTTTCTTTGTCAAGAGCCGTCGCTCTCGTCAGAGCTCGCTGCTC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1681 GGCGTACCAGCGATCGCTTTCTTTGTCAAGAGCCGTCGCTCTCGTCAGAGCTCGCTGCTC 
 
1732 CGCGCGGGCGAGAACACGCCGCTCGTGCGTGGACAGTAA 
     ||||||||||||||||||||||||||||||||||||  |                      
1741 CGCGCGGGCGAGAACACGCCGCTCGTGCGTGGACAGGCAGCAGCCATCATCATCATCATC 
 
Appendix 4 Sequence alignment of 5’his 
Fast alignment of DNA sequences pigh1x.seq and 5’his.seq 
 
Ktuple=2  Gap_penalty=7 
 
Upper line: pigh1x.seq, from 1 to 1769 
Lower line: 5’his.seq, from 67 to 1835 
 
pigh1x.seq:5’his.seq identity= 100.00%(1770/1770) gap=0.00%(0/1770) 
1    ATGAAGTGTCTGCAACTGCTTCTGGCTGGCGTCTCGGCCGTGCTCGCGACTGTGAGTGCG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
67   ATGAAGTGTCTGCAACTGCTTCTGGCTGGCGTCTCGGCCGTGCTCGCGACTGTGAGTGCG 
 
61   AGCGCTGTCGTCACCACCTCCGCGAGTGCCAAGCGCTGCTTCCCGGACGACTTCCTCTTT 
57 
 
 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
127  AGCGCTGTCGTCACCACCTCCGCGAGTGCCAAGCGCTGCTTCCCGGACGACTTCCTCTTT 
 
121  GGCTCTGCCACCGCCGCATACCAAGTGGAGGGCGCTTGGAACGAGACCGGCCGAACGCCG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
187  GGCTCTGCCACCGCCGCATACCAAGTGGAGGGCGCTTGGAACGAGACCGGCCGAACGCCG 
 
181  TCAATCTGGGACGACTTCTGTCGCGAGAAGCCCGGTCTTCAGTGCTCGAACGTCGCCGAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
247  TCAATCTGGGACGACTTCTGTCGCGAGAAGCCCGGTCTTCAGTGCTCGAACGTCGCCGAC 
 
241  GACTTCTACCACCGGTACGTGAGCGACATCCAGACGATGGTCGACTCGGGATTGGACTCG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
307  GACTTCTACCACCGGTACGTGAGCGACATCCAGACGATGGTCGACTCGGGATTGGACTCG 
 
301  TTCCGCTTCAGCATCTCCTGGTCGCGCGCCATGAACTGGGACCCTGCGACCAAGAAGATG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
367  TTCCGCTTCAGCATCTCCTGGTCGCGCGCCATGAACTGGGACCCTGCGACCAAGAAGATG 
 
361  AAGCCCAACCCGCAAGGCATCGCCTTCTACCACGCGCTCATCGACGAGCTCAAGCGCAAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
427  AAGCCCAACCCGCAAGGCATCGCCTTCTACCACGCGCTCATCGACGAGCTCAAGCGCAAC 
 
421  AATATCGTGCCGATCTTGACGCTCTACCACTGGGACCTCCCGAGCGAATTGCACAGTGAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
487  AATATCGTGCCGATCTTGACGCTCTACCACTGGGACCTCCCGAGCGAATTGCACAGTGAG 
 
481  CTCAAGCCGCAGGGTTGGCTCAACCGCGAGATCATCGATCACTTCGTTGAGTACTCGGAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
547  CTCAAGCCGCAGGGTTGGCTCAACCGCGAGATCATCGATCACTTCGTTGAGTACTCGGAG 
 
541  CTCATATTCAACGAGTTTGGCAAGAAGGTGGACATGTGGACGACGTTCAATGAGCCGCTG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
607  CTCATATTCAACGAGTTTGGCAAGAAGGTGGACATGTGGACGACGTTCAATGAGCCGCTG 
 
601  TCGTTCGTCTCCCAGGGCTACGCAACGGGCATGTCGGCTCCAGGATACACCAACTCCAAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
667  TCGTTCGTCTCCCAGGGCTACGCAACGGGCATGTCGGCTCCAGGATACACCAACTCCAAG 
 
661  ACGAACGCGTACGTTGTCGCGCACAACGTGCTGCTCTCGCACGGCAAGGCGGTGCAGCGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
727  ACGAACGCGTACGTTGTCGCGCACAACGTGCTGCTCTCGCACGGCAAGGCGGTGCAGCGC 
 
721  TTCCGCGAGCTCAAGAAGAGCAACGTCGTCCATGAGAAGGCGCGCATCGGTATCGTGATT 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
787  TTCCGCGAGCTCAAGAAGAGCAACGTCGTCCATGAGAAGGCGCGCATCGGTATCGTGATT 
 
781  GTCGACCACTTCTACTACCCTCTCGACCCGAGCAACCCGCGCGACGTCATTGCGGCTGAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
847  GTCGACCACTTCTACTACCCTCTCGACCCGAGCAACCCGCGCGACGTCATTGCGGCTGAG 
 
841  CGCGCGATCCAGTTTGGATTCGGCTGGTTCTTCATTCCCATAGTGACTGGCAAGTATCCA 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
907  CGCGCGATCCAGTTTGGATTCGGCTGGTTCTTCATTCCCATAGTGACTGGCAAGTATCCA 
 
901  GACGTGATGCGCGAACGTGTCGGTGACCGCCTGCCAGAGTTCACGGCGGAGGAAGCTGCG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
58 
 
 
967  GACGTGATGCGCGAACGTGTCGGTGACCGCCTGCCAGAGTTCACGGCGGAGGAAGCTGCG 
 
961  ATGGTAAAGGACTCGTACGACCTCTTCATGCTCAACCACTACTCATCCCACACTGTGACG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1027 ATGGTAAAGGACTCGTACGACCTCTTCATGCTCAACCACTACTCATCCCACACTGTGACG 
 
1021 GACTGCGACTCCGAAACGTCGCTCGTCAAGTGCAGCGATTTGTCCCTCGGATGGGAACAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1087 GACTGCGACTCCGAAACGTCGCTCGTCAAGTGCAGCGATTTGTCCCTCGGATGGGAACAG 
 
1081 GATATGGGCGTCGACAGTACGCGTGCGCCAGACGGTGCGCGTCTGTCCAGCAAGAACAGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1147 GATATGGGCGTCGACAGTACGCGTGCGCCAGACGGTGCGCGTCTGTCCAGCAAGAACAGC 
 
1141 CTCGGCGAGTACAACTGCAAGTGGTTCACGGGATACCCGGCAGGCTACCTGGAAATGATC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1207 CTCGGCGAGTACAACTGCAAGTGGTTCACGGGATACCCGGCAGGCTACCTGGAAATGATC 
 
1201 AAGTGGATGCACAAGTACAACACAAAGGCGGACATCTTACTCACCGAGAACGGCTGGTGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1267 AAGTGGATGCACAAGTACAACACAAAGGCGGACATCTTACTCACCGAGAACGGCTGGTGC 
 
1261 GGCAACGAGACCATCGACAACCAGGACCAACTCTGGTACTTCCAGAGCTACATCGGCGAA 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1327 GGCAACGAGACCATCGACAACCAGGACCAACTCTGGTACTTCCAGAGCTACATCGGCGAA 
 
1321 GTCTACAAGGCGATCAACGAACTCAAGATCCCCATCATTGGGTACACTGCGTGGTCGTTC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1387 GTCTACAAGGCGATCAACGAACTCAAGATCCCCATCATTGGGTACACTGCGTGGTCGTTC 
 
1381 ATGGACAACTACGAGTGGGGCTCATTCAAGCCTCGCTTTGGACTCTACTACGTCAATTTC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1447 ATGGACAACTACGAGTGGGGCTCATTCAAGCCTCGCTTTGGACTCTACTACGTCAATTTC 
 
1441 ACGTCCGAGACCGGCAAGGCGGATGAGGTCACCCCAGGATCAAACGCCTTGGCACGCATC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1507 ACGTCCGAGACCGGCAAGGCGGATGAGGTCACCCCAGGATCAAACGCCTTGGCACGCATC 
 
1501 CCACGTCCTGCGGCCAAATGGTACGCGCAAGTGGCGAAGACCAAGTGCCTCGACGGCTTT 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1567 CCACGTCCTGCGGCCAAATGGTACGCGCAAGTGGCGAAGACCAAGTGCCTCGACGGCTTT 
 
1561 GAGATTGAAGGCGTGCCAGTCTTGGCAGGAGTCAGCGACGTTACTGGTACCAGCTCTGGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1627 GAGATTGAAGGCGTGCCAGTCTTGGCAGGAGTCAGCGACGTTACTGGTACCAGCTCTGGC 
 
1621 AGCAGCTTTAAGACGTTCGCACTCTGGGGGCTGGTGCTGGGTGTTGTTGTCGGCGTACCA 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1687 AGCAGCTTTAAGACGTTCGCACTCTGGGGGCTGGTGCTGGGTGTTGTTGTCGGCGTACCA 
 
1681 GCGATCGCTTTCTTTGTCAAGAGCCGTCGCTCTCGTCAGAGCTCGCTGCTCCGCGCGGGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1747 GCGATCGCTTTCTTTGTCAAGAGCCGTCGCTCTCGTCAGAGCTCGCTGCTCCGCGCGGGC 
 
1741 GAGAACACGCCGCTCGTGCGTGGACAGTAA 
     ||||||||||||||||||||||||||||||           
1807 GAGAACACGCCGCTCGTGCGTGGACAGTAAGGATCCGGGA 
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Appendix 5 Sequence alignment of short 
Fast alignment of DNA sequences short.seq and tPiGH1-x.seq 
 
Ktuple=2  Gap_penalty=7 
 
Upper line: short.seq, from 1 to 1799 
Lower line: tPiGH1-x.seq, from 1 to 1799 
 
short.seq:tPiGH1-x.seq identity= 100.00%(1800/1800) gap=0.00%(0/1800) 
1    TTTTCCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCGAAAACTTGTATTTC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1    TTTTCCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCGAAAACTTGTATTTC 
 
61   CAAAGTAGCGCTGTCGTCACCACCTCCGCGAGTGCCAAGCGCTGCTTCCCGGACGACTTC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
61   CAAAGTAGCGCTGTCGTCACCACCTCCGCGAGTGCCAAGCGCTGCTTCCCGGACGACTTC 
 
121  CTCTTTGGCTCTGCCACCGCCGCATACCAAGTGGAGGGCGCTTGGAACGAGACCGGCCGA 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
121  CTCTTTGGCTCTGCCACCGCCGCATACCAAGTGGAGGGCGCTTGGAACGAGACCGGCCGA 
 
181  ACGCCGTCAATCTGGGACGACTTCTGTCGCGAGAAGCCCGGTCTTCAGTGCTCGAACGTC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
181  ACGCCGTCAATCTGGGACGACTTCTGTCGCGAGAAGCCCGGTCTTCAGTGCTCGAACGTC 
 
241  GCCGACGACTTCTACCACCGGTACGTGAGCGACATCCAGACGATGGTCGACTCGGGATTG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
241  GCCGACGACTTCTACCACCGGTACGTGAGCGACATCCAGACGATGGTCGACTCGGGATTG 
 
301  GACTCGTTCCGCTTCAGCATCTCCTGGTCGCGCGCCATGAACTGGGACCCTGCGACCAAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
301  GACTCGTTCCGCTTCAGCATCTCCTGGTCGCGCGCCATGAACTGGGACCCTGCGACCAAG 
 
361  AAGATGAAGCCCAACCCGCAAGGCATCGCCTTCTACCACGCGCTCATCGACGAGCTCAAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
361  AAGATGAAGCCCAACCCGCAAGGCATCGCCTTCTACCACGCGCTCATCGACGAGCTCAAG 
 
421  CGCAACAATATCGTGCCGATCTTGACGCTCTACCACTGGGACCTCCCGAGCGAATTGCAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
421  CGCAACAATATCGTGCCGATCTTGACGCTCTACCACTGGGACCTCCCGAGCGAATTGCAC 
 
481  AGTGAGCTCAAGCCGCAGGGTTGGCTCAACCGCGAGATCATCGATCACTTCGTTGAGTAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
481  AGTGAGCTCAAGCCGCAGGGTTGGCTCAACCGCGAGATCATCGATCACTTCGTTGAGTAC 
 
541  TCGGAGCTCATATTCAACGAGTTTGGCAAGAAGGTGGACATGTGGACGACGTTCAATGAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
541  TCGGAGCTCATATTCAACGAGTTTGGCAAGAAGGTGGACATGTGGACGACGTTCAATGAG 
 
601  CCGCTGTCGTTCGTCTCCCAGGGCTACGCAACGGGCATGTCGGCTCCAGGATACACCAAC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
601  CCGCTGTCGTTCGTCTCCCAGGGCTACGCAACGGGCATGTCGGCTCCAGGATACACCAAC 
 
60 
 
 
661  TCCAAGACGAACGCGTACGTTGTCGCGCACAACGTGCTGCTCTCGCACGGCAAGGCGGTG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
661  TCCAAGACGAACGCGTACGTTGTCGCGCACAACGTGCTGCTCTCGCACGGCAAGGCGGTG 
 
721  CAGCGCTTCCGCGAGCTCAAGAAGAGCAACGTCGTCCATGAGAAGGCGCGCATCGGTATC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
721  CAGCGCTTCCGCGAGCTCAAGAAGAGCAACGTCGTCCATGAGAAGGCGCGCATCGGTATC 
 
781  GTGATTGTCGACCACTTCTACTACCCTCTCGACCCGAGCAACCCGCGCGACGTCATTGCG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
781  GTGATTGTCGACCACTTCTACTACCCTCTCGACCCGAGCAACCCGCGCGACGTCATTGCG 
 
841  GCTGAGCGCGCGATCCAGTTTGGATTCGGCTGGTTCTTCATTCCCATAGTGACTGGCAAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
841  GCTGAGCGCGCGATCCAGTTTGGATTCGGCTGGTTCTTCATTCCCATAGTGACTGGCAAG 
 
901  TATCCAGACGTGATGCGCGAACGTGTCGGTGACCGCCTGCCAGAGTTCACGGCGGAGGAA 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
901  TATCCAGACGTGATGCGCGAACGTGTCGGTGACCGCCTGCCAGAGTTCACGGCGGAGGAA 
 
961  GCTGCGATGGTAAAGGACTCGTACGACCTCTTCATGCTCAACCACTACTCATCCCACACT 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
961  GCTGCGATGGTAAAGGACTCGTACGACCTCTTCATGCTCAACCACTACTCATCCCACACT 
 
1021 GTGACGGACTGCGACTCCGAAACGTCGCTCGTCAAGTGCAGCGATTTGTCCCTCGGATGG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1021 GTGACGGACTGCGACTCCGAAACGTCGCTCGTCAAGTGCAGCGATTTGTCCCTCGGATGG 
 
1081 GAACAGGATATGGGCGTCGACAGTACGCGTGCGCCAGACGGTGCGCGTCTGTCCAGCAAG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1081 GAACAGGATATGGGCGTCGACAGTACGCGTGCGCCAGACGGTGCGCGTCTGTCCAGCAAG 
 
1141 AACAGCCTCGGCGAGTACAACTGCAAGTGGTTCACGGGATACCCGGCAGGCTACCTGGAA 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1141 AACAGCCTCGGCGAGTACAACTGCAAGTGGTTCACGGGATACCCGGCAGGCTACCTGGAA 
 
1201 ATGATCAAGTGGATGCACAAGTACAACACAAAGGCGGACATCTTACTCACCGAGAACGGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1201 ATGATCAAGTGGATGCACAAGTACAACACAAAGGCGGACATCTTACTCACCGAGAACGGC 
 
1261 TGGTGCGGCAACGAGACCATCGACAACCAGGACCAACTCTGGTACTTCCAGAGCTACATC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1261 TGGTGCGGCAACGAGACCATCGACAACCAGGACCAACTCTGGTACTTCCAGAGCTACATC 
 
1321 GGCGAAGTCTACAAGGCGATCAACGAACTCAAGATCCCCATCATTGGGTACACTGCGTGG 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1321 GGCGAAGTCTACAAGGCGATCAACGAACTCAAGATCCCCATCATTGGGTACACTGCGTGG 
 
1381 TCGTTCATGGACAACTACGAGTGGGGCTCATTCAAGCCTCGCTTTGGACTCTACTACGTC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1381 TCGTTCATGGACAACTACGAGTGGGGCTCATTCAAGCCTCGCTTTGGACTCTACTACGTC 
 
1441 AATTTCACGTCCGAGACCGGCAAGGCGGATGAGGTCACCCCAGGATCAAACGCCTTGGCA 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1441 AATTTCACGTCCGAGACCGGCAAGGCGGATGAGGTCACCCCAGGATCAAACGCCTTGGCA 
 
1501 CGCATCCCACGTCCTGCGGCCAAATGGTACGCGCAAGTGGCGAAGACCAAGTGCCTCGAC 
61 
 
 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1501 CGCATCCCACGTCCTGCGGCCAAATGGTACGCGCAAGTGGCGAAGACCAAGTGCCTCGAC 
 
1561 GGCTTTGAGATTGAAGGCGTGCCAGTCTTGGCAGGAGTCAGCGACGTTACTGGTACCAGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1561 GGCTTTGAGATTGAAGGCGTGCCAGTCTTGGCAGGAGTCAGCGACGTTACTGGTACCAGC 
 
1621 TCTGGCAGCAGCTTTAAGACGTTCGCACTCTGGGGGCTGGTGCTGGGTGTTGTTGTCGGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1621 TCTGGCAGCAGCTTTAAGACGTTCGCACTCTGGGGGCTGGTGCTGGGTGTTGTTGTCGGC 
 
1681 GTACCAGCGATCGCTTTCTTTGTCAAGAGCCGTCGCTCTCGTCAGAGCTCGCTGCTCCGC 
     |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
1681 GTACCAGCGATCGCTTTCTTTGTCAAGAGCCGTCGCTCTCGTCAGAGCTCGCTGCTCCGC 
 
1741 GCGGGCGAGAACACGCCGCTCGTGCGTGGACAGTAAGGATCCGGGA 
     |||||||||||||||||||||||||||||||||||||||||||||| 
1741 GCGGGCGAGAACACGCCGCTCGTGCGTGGACAGTAAGGATCCGGGA 
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